Viking Therapeutics, Inc. (VKTX) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Viking Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • Viking Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$405 M, a 30.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$405 M -$93.7 M -30.1% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$378 M -$85.9 M -29.4% Dec 31, 2023 10-Q 2024-04-25
Q3 2023 -$353 M -$80.8 M -29.7% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 -$331 M -$74.1 M -28.9% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 -$312 M -$72.3 M -30.2% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 -$292 M -$68.9 M -30.9% Dec 31, 2022 10-K 2024-02-07
Q3 2022 -$272 M -$61.7 M -29.2% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 -$257 M -$59.1 M -29.9% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 -$239 M -$57.1 M -31.3% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 -$223 M -$55 M -32.7% Dec 31, 2021 10-K 2023-02-10
Q3 2021 -$211 M -$53.6 M -34.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 -$198 M -$49.6 M -33.5% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 -$182 M -$43.8 M -31.7% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 -$168 M -$39.5 M -30.7% Dec 31, 2020 10-K 2022-02-09
Q3 2020 -$157 M -$36 M -29.7% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 -$148 M -$32.4 M -28.1% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 -$138 M -$30.5 M -28.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 -$129 M -$25.8 M -25% Dec 31, 2019 10-K 2021-02-17
Q3 2019 -$121 M -$23.6 M -24.1% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$116 M -$24.4 M -26.8% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 -$108 M -$23.4 M -27.8% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 -$103 M -$22.1 M -27.3% Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$97.7 M -$20.9 M -27.2% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$91.1 M -$20.4 M -28.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$84.4 M -$18.9 M -28.9% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 -$80.9 M -$20.6 M -34.1% Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$76.8 M -$20.1 M -35.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$70.7 M -$17.8 M -33.8% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$65.5 M -$16.4 M -33.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$60.3 M -$14.7 M -32.3% Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$56.6 M -$16.2 M -40% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$52.8 M -$17.1 M -47.9% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 -$49.1 M -$21.3 M -76.4% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$45.5 M -$23.4 M -106% Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$40.5 M Sep 30, 2015 10-Q 2015-11-05
Q2 2015 -$35.7 M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 -$27.9 M Mar 31, 2015 10-Q 2015-06-12
Q4 2014 -$22.1 M Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.